Vericel (VCEL) Retained Earnings (2010 - 2026)
Vericel (VCEL) reported Retained Earnings of -$382.6 million for Q1 2026, up 5.31% on a YoY basis from -$363.3 million in Q1 2025, and down 1.68% sequentially from -$376.3 million in Q4 2025.
Vericel (VCEL) Retained Earnings (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Retained Earnings data on file, last reported at -$382.6 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 5.31% year-over-year to -$382.6 million; the trailing twelve-month figure through Mar 2026 stood at -$382.6 million (up 5.31% YoY), and the FY2025 full-year result was -$376.3 million, up 4.21% from the prior year.
- Retained Earnings eased to -$382.6 million in Q1 2026, from -$376.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $359000.0 in Q3 2024 to a low of -$416.2 million in Q3 2023.
- A 5-year average of -$305.9 million and a median of -$399.5 million in 2025 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings plunged 1764682.61% in 2022 and soared 100.09% in 2024, its largest moves.
- Tracing VCEL's Retained Earnings over 5 years: stood at -$400.0 million in 2022, then surged by 99.97% to -$100000.0 in 2023, then sank by 392715.0% to -$392.8 million in 2024, then advanced by 4.21% to -$376.3 million in 2025, then declined by 1.68% to -$382.6 million in 2026.
- Business Quant data shows VCEL's Retained Earnings at -$382.6 million in Q1 2026, -$376.3 million in Q4 2025, and -$399.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | -382.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -382.60 Mn |
| Dec 31, 2025 | -376.30 Mn |
| Sep 30, 2025 | -399.50 Mn |
| Jun 30, 2025 | -404.60 Mn |
| Mar 31, 2025 | -404.06 Mn |
| Dec 31, 2024 | -392.82 Mn |
| Sep 30, 2024 | 359,000.00 |
| Jun 30, 2024 | -411.72 Mn |
| Mar 31, 2024 | -407.04 Mn |
| Dec 31, 2023 | -100,000.00 |
| Sep 30, 2023 | -416.17 Mn |
| Jun 30, 2023 | -621,000.00 |
| Mar 31, 2023 | -407.49 Mn |
| Dec 31, 2022 | -400.00 Mn |
| Sep 30, 2022 | -405.90 Mn |
| Jun 30, 2022 | -855,000.00 |
| Mar 31, 2022 | -390.40 Mn |
| Dec 31, 2021 | -383.29 Mn |
| Sep 30, 2021 | -23,000.00 |
| Jun 30, 2021 | -382.90 Mn |